About
Eric Bjerkholt is a biopharmaceutical finance executive and public-company board member. He has served as Chief Financial Officer of Mirum Pharmaceuticals since September 2023, after prior CFO roles at Chinook Therapeutics, Aimmune Therapeutics, Sunesis Pharmaceuticals, IntraBiotics Pharmaceuticals, LifeSpring Nutrition, and Age Wave. He also serves on biotech boards including Metagenomi, Cerus, and Surrozen, bringing corporate finance, investor relations, and governance experience across rare disease and genetic medicines.
Areas of interest
biotechrare disease therapeuticsgenetic medicinegene editingregenerative medicineblood safetycorporate financeinvestor relationspublic company governance